Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Cervical Cancer

  Free Subscription


12.02.2018

1 Acta Oncol
1 Am J Med
1 Angew Chem Int Ed Engl
1 BMC Cancer
1 Brachytherapy
1 Cancer Biol Ther
1 Cancer Epidemiol
1 Cancer Manag Res
1 Clin Imaging
1 Epidemiol Serv Saude
1 Eur J Med Chem
1 Exp Ther Med
1 Gac Med Mex
1 Gene
2 Gynecol Oncol
1 Int J Cancer
6 Int J Gynecol Cancer
1 Int J Radiat Oncol Biol Phys
1 J Adolesc Young Adult Oncol
2 J Gynecol Oncol
1 J Obstet Gynaecol
1 J Prim Care Community Health
1 J Public Health Afr
1 Lancet Oncol
1 Med Arch
1 Med Phys
1 Med Sci (Basel)
2 Medicine (Baltimore)
1 MMW Fortschr Med
1 Mol Med Rep
1 Nanomedicine
1 Oncol Lett
3 Oncol Rep
6 Oncotarget
1 Phytother Res
1 PLoS One
1 Public Health
1 Reprod Sci
1 Soc Work Public Health
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Oncol

  1. LUND KV, Simonsen TG, Kristensen GB, Rofstad EK, et al
    Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
    Acta Oncol. 2017;56:675-681.
    PubMed     Text format     Abstract available


    Am J Med

  2. ZHANG S, McNamara M, Batur P
    Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
    Am J Med. 2018 Feb 2. pii: S0002-9343(18)30095.
    PubMed     Text format     Abstract available


    Angew Chem Int Ed Engl

  3. WANG N, Wang Z, Xu Z, Chen X, et al
    A cisplatin-loaded immuno-chemotherapeutic nanohybrid bearing immune checkpoint inhibitors for enhanced cervical cancer therapy.
    Angew Chem Int Ed Engl. 2018 Feb 5. doi: 10.1002/anie.201800422.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. COSTA RFA, Longatto-Filho A, de Lima Vazquez F, Pinheiro C, et al
    Trend analysis of the quality indicators for the Brazilian cervical cancer screening programme by region and state from 2006 to 2013.
    BMC Cancer. 2018;18:126.
    PubMed     Text format     Abstract available


    Brachytherapy

  5. SKLIARENKO J, Carlone M, Tanderup K, Han K, et al
    Technique adaptation, strategic replanning, and team learning during implementation of MR-guided brachytherapy for cervical cancer.
    Brachytherapy. 2018;17:86-93.
    PubMed     Text format     Abstract available


    Cancer Biol Ther

  6. LI J, Chen L, Liu Q, Tang M, et al
    Buformin suppresses proliferation and invasion via AMPK/S6 pathway in cervical cancer and synergizes with paclitaxel.
    Cancer Biol Ther. 2018 Feb 5:0. doi: 10.1080/15384047.2018.1433504.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  7. STEWART TS, Moodley J, Walter FM
    Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
    Cancer Epidemiol. 2018;53:81-92.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  8. FENG YC, Ji WL, Yue N, Huang YC, et al
    The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance.
    Cancer Manag Res. 2018;10:105-113.
    PubMed     Text format     Abstract available


    Clin Imaging

  9. XU Y, Ru T, Zhu L, Liu B, et al
    Ultrasonic histogram assessment of early response to concurrent chemo-radiotherapy in patients with locally advanced cervical cancer: a feasibility study.
    Clin Imaging. 2018;49:144-149.
    PubMed     Text format     Abstract available


    Epidemiol Serv Saude

  10. RIBEIRO CM, Silva GAE
    Assessment of the production of cervical cancer care procedures in the Brazilian National Health System in 2015.
    Epidemiol Serv Saude. 2018;27:e20172124.
    PubMed     Text format     Abstract available


    Eur J Med Chem

  11. LASKAR S, Sanchez-Sanchez L, Flores SM, Lopez-Munoz H, et al
    Identification of (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamate-nitrostyrene hybrid as potent antiproliferative and apoptotic inducing agent against cervical cancer cell lines.
    Eur J Med Chem. 2018;146:621-635.
    PubMed     Text format     Abstract available


    Exp Ther Med

  12. WANG P, Zhang L, Zhang J, Xu G, et al
    MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.
    Exp Ther Med. 2018;15:1385-1393.
    PubMed     Text format     Abstract available


    Gac Med Mex

  13. GOMEZ MC, Abaunza MC, Vargas EJ, Acosta I, et al
    [Squamous cell carcinoma in situ of the cervix and placental site nodule: Case report].
    Gac Med Mex. 2017;153:397-400.
    PubMed     Text format     Abstract available


    Gene

  14. SITOLE BN, Mavri-Damelin D
    Peroxidasin is regulated by the epithelial-mesenchymal transition master transcription factor Snai1.
    Gene. 2018;646:195-202.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  15. THARAVICHITKUL E, Chakrabandhu S, Klunklin P, Onchan W, et al
    Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer.
    Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30047.
    PubMed     Text format     Abstract available

  16. ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
    Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. LECAVALIER-BARSOUM M, Chaudary N, Han K, Koritzinsky M, et al
    Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer.
    Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31297.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  18. LUAN T, Hua Q, Liu X, Xu P, et al
    PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
    Int J Gynecol Cancer. 2017;27:1480-1488.
    PubMed     Text format     Abstract available

  19. JUNG EJ, Byun JM, Kim YN, Lee KB, et al
    Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1228-1236.
    PubMed     Text format     Abstract available

  20. HONG MK, Wang JH, Su CC, Li MH, et al
    Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.
    Int J Gynecol Cancer. 2017;27:1247-1255.
    PubMed     Text format     Abstract available

  21. LUO L, Zhang H, Nian S, Lv C, et al
    Up-regulation of Transcription Factor 3 Is Correlated With Poor Prognosis in Cervical Carcinoma.
    Int J Gynecol Cancer. 2017;27:1422-1430.
    PubMed     Text format     Abstract available

  22. CHENG J, Hou Y, Li J, Wang W, et al
    Agreement Between Magnetic Resonance Imaging and Pathologic Findings in the Tumor Size Evaluation Before and After Neoadjuvant Chemotherapy Treatment: A Prospective Study.
    Int J Gynecol Cancer. 2017;27:1472-1479.
    PubMed     Text format     Abstract available

  23. LI X, Wang L, Li Y, Song P, et al
    The Value of Diffusion-Weighted Imaging in Combination With Conventional Magnetic Resonance Imaging for Improving Tumor Detection for Early Cervical Carcinoma Treated With Fertility-Sparing Surgery.
    Int J Gynecol Cancer. 2017;27:1761-1768.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  24. VULPE H, Asamoah FA, Maganti M, Vanderpuye V, et al
    External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Int J Radiat Oncol Biol Phys. 2017 Dec 21. pii: S0360-3016(17)34493.
    PubMed     Text format     Abstract available


    J Adolesc Young Adult Oncol

  25. ANGHEL RM, Trifanescu OG, Mitrica RI, Curea FG, et al
    Good Prognosis Went Badly: Fulminant Evolution of a 29-Year-Old Patient with Verrucous Carcinoma of the Cervix.
    J Adolesc Young Adult Oncol. 2017;6:499-502.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  26. MIKAMI M, Shida M, Shibata T, Katabuchi H, et al
    Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer.
    J Gynecol Oncol. 2017 Dec 27. pii: 29.e23. doi: 10.3802/jgo.2018.
    PubMed     Text format     Abstract available

  27. SHIM SH, Kim SN, Chae SH, Kim JE, et al
    Impact of adjuvant hysterectomy on prognosis in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy: a meta-analysis.
    J Gynecol Oncol. 2018 Jan 5. pii: 29.e25. doi: 10.3802/jgo.2018.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol

  28. EMMETT M, Gildea C, Nordin A, Hirschowitz L, et al
    Cervical cancer - does the morphological subtype affect survival rates?
    J Obstet Gynaecol. 2018 Feb 6:1-8. doi: 10.1080/01443615.2017.1379062.
    PubMed     Text format     Abstract available


    J Prim Care Community Health

  29. LOKE AY, Kwan ML, Wong YT, Wong AKY, et al
    The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review.
    J Prim Care Community Health. 2017;8:349-362.
    PubMed     Text format     Abstract available


    J Public Health Afr

  30. GANA GJ, Oche MO, Ango JT, Kaoje AU, et al
    Educational intervention on knowledge of cervical cancer and uptake of Pap smear test among market women in Niger State, Nigeria.
    J Public Health Afr. 2017;8:575.
    PubMed     Text format     Abstract available


    Lancet Oncol

  31. DAS M
    Cervical cancer vaccine controversy in India.
    Lancet Oncol. 2018;19:e84.
    PubMed     Text format    


    Med Arch

  32. ALEKSIOSKA-PAPESTIEV I, Chibisheva V, Micevska M, Dimitrov G, et al
    Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Med Arch. 2018;72:26-30.
    PubMed     Text format     Abstract available


    Med Phys

  33. THO D, Racine E, Easton H, Song WY, et al
    Technical Note: On EM Reconstruction of a Multi Channel Shielded Applicator for Cervical Cancer Brachytherapy: A Feasibility Study.
    Med Phys. 2018 Feb 5. doi: 10.1002/mp.12789.
    PubMed     Text format     Abstract available


    Med Sci (Basel)


  34. Immunotherapy: A New Strategy for the Treatment of Cervical Cancer. Interview with Dr. Christian Marth and Dr. Sharad Ghamande.
    Med Sci (Basel). 2018;6.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  35. RYU H, Song IC, Choi YS, Yun HJ, et al
    ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy.
    Medicine (Baltimore). 2017;96:e9402.
    PubMed     Text format     Abstract available

  36. LILI E, Chatzistamatiou K, Kalpaktsidou-Vakiani A, Moysiadis T, et al
    Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up.
    Medicine (Baltimore). 2018;97:e9719.
    PubMed     Text format     Abstract available


    MMW Fortschr Med

  37. STARRACH T, Gallwas J, Blankenstein T, Mahner S, et al
    [Changes to cervical cancer screening in Germany].
    MMW Fortschr Med. 2018;160:46-51.
    PubMed     Text format    


    Mol Med Rep

  38. YU X, Liu Y, Wang Y, Mao X, et al
    Baicalein induces cervical cancer apoptosis through the NF-kappaB signaling pathway.
    Mol Med Rep. 2018 Jan 25. doi: 10.3892/mmr.2018.8493.
    PubMed     Text format     Abstract available


    Nanomedicine

  39. YOKCHOM R, Laiwejpithaya S, Maneeprakorn W, Tapaneeyakorn S, et al
    Paper-based immunosensor with signal amplification by enzyme-labeled anti-p16(INK4a) multifunctionalized gold nanoparticles for cervical cancer screening.
    Nanomedicine. 2018 Feb 3. pii: S1549-9634(18)30027.
    PubMed     Text format     Abstract available


    Oncol Lett

  40. JIA L, Li F, Shao M, Zhang W, et al
    IL-8 is upregulated in cervical cancer tissues and is associated with the proliferation and migration of HeLa cervical cancer cells.
    Oncol Lett. 2018;15:1350-1356.
    PubMed     Text format     Abstract available


    Oncol Rep

  41. LI F, Wang Z, Lu G
    TRIM28 promotes cervical cancer growth through the mTOR signaling pathway.
    Oncol Rep. 2018 Jan 26. doi: 10.3892/or.2018.6235.
    PubMed     Text format     Abstract available

  42. RAMIREZ DE ARELLANO A, Riera Leal A, Lopez-Pulido EI, Gonzalez-Lucano LR, et al
    A 60 kDa prolactin variant secreted by cervical cancer cells modulates apoptosis and cytokine production.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6222.
    PubMed     Text format     Abstract available

  43. PEDROZA-TORRES A, Campos-Parra AD, Millan-Catalan O, Loissell-Baltazar YA, et al
    MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6219.
    PubMed     Text format     Abstract available


    Oncotarget

  44. LU H, Guo R, Yang H, Wang H, et al
    The prognostic value of negative lymph node count for patients with cervical cancer after radical surgery.
    Oncotarget. 2017;9:2810-2818.
    PubMed     Text format     Abstract available

  45. HAN D, Wang J, Cheng G
    LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.
    Oncotarget. 2017;9:2395-2409.
    PubMed     Text format     Abstract available

  46. KIM W, Pyo J, Noh BJ, Jeong JW, et al
    CCAR2 negatively regulates IL-8 production in cervical cancer cells.
    Oncotarget. 2017;9:1143-1155.
    PubMed     Text format     Abstract available

  47. XU S, Du X, Feng G, Zhang Y, et al
    Efficient inhibition of cervical cancer by dual drugs loaded in biodegradable thermosensitive hydrogel composites.
    Oncotarget. 2017;9:282-292.
    PubMed     Text format     Abstract available

  48. ZHENG D, Mou HP, Diao P, Li XM, et al
    Chemoradiotherapy in combination with radical surgery is associated with better outcome in cervical cancer patients.
    Oncotarget. 2017;9:2866-2875.
    PubMed     Text format     Abstract available

  49. LEE JW, Yang DH, Park S, Han HK, et al
    Trichostatin A resistance is facilitated by HIF-1alpha acetylation in HeLa human cervical cancer cells under normoxic conditions.
    Oncotarget. 2017;9:2035-2049.
    PubMed     Text format     Abstract available


    Phytother Res

  50. POTOCNJAK I, Gobin I, Domitrovic R
    Carvacrol induces cytotoxicity in human cervical cancer cells but causes cisplatin resistance: Involvement of MEK-ERK activation.
    Phytother Res. 2018 Feb 8. doi: 10.1002/ptr.6048.
    PubMed     Text format     Abstract available


    PLoS One

  51. JAUDAN A, Sharma S, Malek SNA, Dixit A, et al
    Induction of apoptosis by pinostrobin in human cervical cancer cells: Possible mechanism of action.
    PLoS One. 2018;13:e0191523.
    PubMed     Text format     Abstract available


    Public Health

  52. PETKEVICIENE J, Ivanauskiene R, Klumbiene J
    Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006-2014.
    Public Health. 2018;156:79-86.
    PubMed     Text format     Abstract available


    Reprod Sci

  53. LIN YH, Hsiao YH, Yang SF, Liu YF, et al
    Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
    Reprod Sci. 2018 Jan 1:1933719118756749. doi: 10.1177/1933719118756749.
    PubMed     Text format     Abstract available


    Soc Work Public Health

  54. FALK D
    A Mixed Methods Review of Education and Patient Navigation Interventions to Increase Breast and Cervical Cancer Screening for Rural Women.
    Soc Work Public Health. 2018 Feb 7:1-14. doi: 10.1080/19371918.2018.1434583.
    PubMed     Text format     Abstract available


    Vaccine

  55. D'ADDARIO M, Redmond S, Scott P, Egli-Gany D, et al
    Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.
    Vaccine. 2017 Apr 25. pii: S0264-410X(17)30448.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: